Department of Gastroenterology, Dokkyo Medical University, Tochigi, Japan.
J Gastroenterol Hepatol. 2010 Feb;25(2):383-6. doi: 10.1111/j.1440-1746.2009.06002.x. Epub 2009 Oct 9.
We investigated the utility and safety of contrast-enhanced ultrasonography using Sonazoid in the diagnosis of hepatic hydrothorax.
The study consisted of seven liver cirrhosis patients with hydrothorax and hydroperitoneum. After obtaining informed consent, Sonazoid was injected intraperitoneally, and enhancement in the peritoneal and pleural cavities was observed.
In all patients, the peritoneal cavity was quickly enhanced after the Sonazoid injection. The pleural cavity was enhanced in five of the seven patients, and these five patients were diagnosed with hepatic hydrothorax. Two patients without enhancement of the pleural cavity were diagnosed with inflammatory hydrothorax.
This is the first report to confirm transdiaphragmatic movement of ascitic fluid into the pleural cavity using contrast-enhanced ultrasonography with Sonazoid. This method can safely detect ascitic flow in real time, and is thus very useful for the diagnosis of hepatic hydrothorax.
我们研究了 SonoVue 超声造影在肝性胸水诊断中的应用价值和安全性。
本研究纳入 7 例肝硬化合并胸水和腹水的患者。征得患者知情同意后,经腹腔内注射 SonoVue,观察腹腔和胸腔的增强情况。
所有患者 SonoVue 注射后腹腔迅速增强,7 例患者中有 5 例胸腔增强,这 5 例患者被诊断为肝性胸水。2 例胸腔无增强的患者被诊断为炎症性胸水。
这是首例应用 SonoVue 超声造影证实腹水通过横膈膜进入胸腔的报道。该方法可以实时安全地检测腹水流动,对肝性胸水的诊断非常有用。